ES2161344T3 - Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares. - Google Patents

Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares.

Info

Publication number
ES2161344T3
ES2161344T3 ES96901344T ES96901344T ES2161344T3 ES 2161344 T3 ES2161344 T3 ES 2161344T3 ES 96901344 T ES96901344 T ES 96901344T ES 96901344 T ES96901344 T ES 96901344T ES 2161344 T3 ES2161344 T3 ES 2161344T3
Authority
ES
Spain
Prior art keywords
pct
basic
oxazolin
sec
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901344T
Other languages
English (en)
Spanish (es)
Inventor
Sergio Lociuro
Pierfausto Seneci
Romeo Ciabatti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosearch Italia SpA
Original Assignee
Biosearch Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch Italia SpA filed Critical Biosearch Italia SpA
Application granted granted Critical
Publication of ES2161344T3 publication Critical patent/ES2161344T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES96901344T 1995-02-07 1996-02-01 Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares. Expired - Lifetime ES2161344T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95101596 1995-02-07

Publications (1)

Publication Number Publication Date
ES2161344T3 true ES2161344T3 (es) 2001-12-01

Family

ID=8218960

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901344T Expired - Lifetime ES2161344T3 (es) 1995-02-07 1996-02-01 Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares.

Country Status (13)

Country Link
US (1) US5891869A (de)
EP (1) EP0808326B1 (de)
JP (1) JP3518606B2 (de)
KR (1) KR100394930B1 (de)
AT (1) ATE205505T1 (de)
AU (1) AU693989B2 (de)
CA (1) CA2212437A1 (de)
DE (1) DE69615155T2 (de)
DK (1) DK0808326T3 (de)
ES (1) ES2161344T3 (de)
PT (1) PT808326E (de)
SI (1) SI0808326T1 (de)
WO (1) WO1996024608A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0801655B1 (de) * 1995-02-07 1998-04-15 Biosearch Italia S.p.A. Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
KR19990082541A (ko) * 1996-02-14 1999-11-25 클라우디오 쿼르타 항생물질 ge2270 c2a, d2 및 e 인자의 유도체
CA2404273A1 (en) * 2000-04-11 2001-10-18 Bristol-Myers Squibb Pharma Company Substituted lactams as inhibitors of a.beta. protein production
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20050090433A1 (en) * 2002-11-18 2005-04-28 Vicuron Pharmaceuticals, Inc Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US6828514B2 (en) * 2003-01-30 2004-12-07 Endicott Interconnect Technologies, Inc. High speed circuit board and method for fabrication
CA2455024A1 (en) * 2003-01-30 2004-07-30 Endicott Interconnect Technologies, Inc. Stacked chip electronic package having laminate carrier and method of making same
US7023707B2 (en) * 2003-01-30 2006-04-04 Endicott Interconnect Technologies, Inc. Information handling system
US7035113B2 (en) * 2003-01-30 2006-04-25 Endicott Interconnect Technologies, Inc. Multi-chip electronic package having laminate carrier and method of making same
PE20121011A1 (es) * 2006-05-31 2012-08-25 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
MX2009006745A (es) * 2006-12-20 2009-08-19 Novartis Ag Macrociclos de amino-tiazol, su uso como compuestos anti-bacterianos y procesos para su produccion.
BRPI0821138A2 (pt) 2007-12-12 2015-06-16 Novatis Ag Aminotiazóis e seus usos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ATE117724T1 (de) * 1989-07-04 1995-02-15 Lepetit Spa Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
ES2071143T3 (es) * 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DK0529410T3 (da) * 1991-08-30 1998-05-11 Biosearch Italia Spa Antibiotikum GE 2270 faktor C2a
EP0801655B1 (de) * 1995-02-07 1998-04-15 Biosearch Italia S.p.A. Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
KR19990082541A (ko) * 1996-02-14 1999-11-25 클라우디오 쿼르타 항생물질 ge2270 c2a, d2 및 e 인자의 유도체

Also Published As

Publication number Publication date
ATE205505T1 (de) 2001-09-15
CA2212437A1 (en) 1996-08-15
JPH10513461A (ja) 1998-12-22
US5891869A (en) 1999-04-06
EP0808326B1 (de) 2001-09-12
EP0808326A1 (de) 1997-11-26
JP3518606B2 (ja) 2004-04-12
DK0808326T3 (da) 2001-10-01
AU693989B2 (en) 1998-07-09
DE69615155T2 (de) 2002-01-17
AU4540096A (en) 1996-08-27
KR19980701995A (ko) 1998-06-25
PT808326E (pt) 2002-02-28
SI0808326T1 (en) 2001-12-31
KR100394930B1 (ko) 2003-12-18
WO1996024608A1 (en) 1996-08-15
DE69615155D1 (de) 2001-10-18

Similar Documents

Publication Publication Date Title
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
DK41193D0 (da) Ionkanalaabnere
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
HRP20060278B1 (hr) 6-0-supstituirani ketolidi antibakterijskog djelovanja
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
BG103947A (en) Derivatives of 9-oxymerythromycin
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
ES2161344T3 (es) Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares.
FI963169A0 (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
ES2115760T3 (es) Derivados de 4''-desoxieritromicina.
DK0801655T3 (da) Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
ATE203246T1 (de) Dialkyltiacumicine
DE69936052D1 (de) N1 modifizierte glycopeptide
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
PL324884A1 (en) Application of prostane derivatives and their compositions with antibiotics in treating bacterial infections
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
PE64099A1 (es) Antibiotico derivado de cefalosporinas
IT1269873B (it) Nuovi derivati chinolonici, sintesi ed impiego come farmaci antibatterici

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 808326

Country of ref document: ES